Our Digital Real World Evidence (RWE) is transforming the way the consumer healthcare and pharmaceutical industry are generating product claims.

Healthcare brands are increasingly under pressure to provide up-to-date, credible medical data to improve or support their pharmaceutical products throughout their lifecycle. The Orbital Research Real World Evidence methodology is backed by the Association of The British Pharmaceutical Industry (ABPI). It has also been reported in:

Digital Health Age British Journal of Nursing EPM European Pharmaceutical Review

“Orbital Research are recognised as the number one world leading experts in Digital Real World Evidence”

- AESGP Conference

In response to this we have launched a pioneering solution – Digital Real World Data Collection – enabling brands to collect medical data in a pertinent, low-cost manner to support licensed indications, patterns of use and outcomes in the real world. Our data collection methodologies and technologies have been applied to this exciting, new medical insight gathering technique, which was originally designed by independent Medical Officer, Dr. Martin Goldman.


The benefits of Digital Real World Evidence

Low-cost alternative to clinical trials; often up to a tenth of the cost.

Data is collected on a large scale, enabling detailed analysis.

Studies can be finished within 6-12 months.

Studies can be conducted into areas where conventional healthcare research is not possible, or difficult.

The data collection process is not governed by clinical trial regulations, offering greater control.

Medical insights provide evidence that can be used to strengthen existing product claims or help develop new ones.